Clinical Trials · NCT07390110
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 25,664
- Start date
- Jan 2026
- Locations
- 1 site, United States
- Primary endpoint
- Composite of worsening heart failure event (exacerbated symptoms of heart failure resulting in hospitalization, intravenous diuretic therapy in an urgent care setting) or all-cause mortality.